Simple, no-cost PCR testing for schools, businesses & events

Fast icon
Results in 24 hours or less
crossed out eye icon
No on-site technician needed for collections
invoice icon
We bill insurance directly
Accuracy icon
94.6% positive and 100% negative agreement with CDC's test
shield with checkmark
FDA authorized
Emergency Use Authorization (EUA) facilitates insurance reimbursement
smiley face icon
Easy collection
Uses a non-invasive saliva sample

SalivaDirect™ is a new process developed at the Yale School of Public Health to test for infection with SARS-CoV-2, the virus that causes COVID-19.

SalivaDirect uses a saliva sample, rather than an invasive nasal or throat sample, to detect the presence of the virus. While it relies on a similar molecular process as earlier tests, it simplifies the test process to drive down costs and ease stress on supply chains.

For groups

Onsite and local tests for schools, events, and businesses

Learn more

For individuals

No-cost and insurance or travel PCR testing with results in 24 hours or less

Learn more

For lab partners

Clinics, public health research, and technology licensing

Learn more

Let’s talk

Find out how can help protect your school, business, or event from COVID.

Request a Quote

SalivaDirect™ has not been FDA cleared or approved. It has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.